{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:48:11Z","timestamp":1792522091440,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["pathophysiologyjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.pathophys.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T04:16:46Z","timestamp":1497154606000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Interleukin-6 participation in pathology of ocular diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Forouhe","family":"Zahir-Jouzdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Atyabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Mojtabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2016.06.045","article-title":"Development and in vitro evaluation of Zeta potential changing self-emulsifying drug delivery systems for enhanced mucus Permeation","volume":"510","author":"Suchaoin","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0010","first-page":"2400","article-title":"IL-6 induction in desiccated corneal epithelium in vitro and in vivo","volume":"17","author":"Higuchi","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/939602","article-title":"Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome","volume":"2010","author":"Cvenkel","year":"2010","journal-title":"Mediators Inflamm."},{"issue":"62","key":"10.1016\/j.pathophys.2017.05.005_bib0020","first-page":"16535","article-title":"Interleukin-6 cytokine: a multifunctional glycoprotein for cancer","volume":"9","author":"Zarogoulidis","year":"2013","journal-title":"Immunome Res."},{"issue":"23","key":"10.1016\/j.pathophys.2017.05.005_bib0025","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.febslet.2011.03.023","article-title":"Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases","volume":"585","author":"Tanaka","year":"2011","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijbs.4666","article-title":"Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases","volume":"8","author":"Tanaka","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157339710803140210193939","article-title":"Therapeutic implications of tocilizumab, a humanized anti-interleukin-6 receptor antibody, for various immune-mediated diseases: an update review","volume":"8","author":"Tanaka","year":"2012","journal-title":"Curr. Rheumatol. Rev."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10384-011-0002-x","article-title":"Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface","volume":"55","author":"Sugaya","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0045","first-page":"1864","article-title":"Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells","volume":"16","author":"Wu","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0050","first-page":"2552","article-title":"Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales\u2019 disease","volume":"17","author":"Sen","year":"2011","journal-title":"Mol. Vis."},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00417-002-0497-4","article-title":"Biology of interleukin-5 in ocular cicatricial pemphigoid","volume":"240","author":"Letko","year":"2002","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0060","first-page":"78","article-title":"Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1","volume":"33","author":"Planck","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0065","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1167\/iovs.11-9417","article-title":"Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye diseasetear cytokines, chemokines, and soluble receptors in DED","volume":"53","author":"Na","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","article-title":"Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses","volume":"91","author":"Hohki","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.archoralbio.2010.09.016","article-title":"Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1\/2 pathway via AT1 receptor","volume":"56","author":"Guo","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0080","first-page":"335","article-title":"Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease","volume":"5","author":"Attaran","year":"2010","journal-title":"Int. J. Chronic Obstr. Pulm Dis."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0085","article-title":"Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritis","volume":"2012","author":"Tada","year":"2012","journal-title":"Case Rep. Rheumatol."},{"issue":"11","key":"10.1016\/j.pathophys.2017.05.005_bib0090","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.bmc.2010.04.031","article-title":"Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier","volume":"18","author":"Kang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.pathophys.2017.05.005_bib0100","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1167\/iovs.11-7956","article-title":"Role of the IL-6 classic-and trans-signaling pathways in corneal sterile inflammation and wound healing","volume":"52","author":"Ebihara","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0105","first-page":"2123","article-title":"TGF-\u03b2-induced interleukin-6 participates in transdifferentiation of human Tenon\u2019s fibroblasts to myofibroblasts","volume":"15","author":"Seong","year":"2009","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nbd.2012.07.026","article-title":"Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells","volume":"48","author":"Chidlow","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1167\/iovs.10-5317","article-title":"Cell proliferation and interleukin-6?Type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma","volume":"52","author":"Johnson","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"118","key":"10.1016\/j.pathophys.2017.05.005_bib0120","first-page":"2","article-title":"Tumor necrosis factor-\u03b1 and interleukin-6 levels in patients with primary open-angle glaucoma","volume":"2","author":"Ghanem","year":"2011","journal-title":"J. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0125","first-page":"168","article-title":"Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina","volume":"1","author":"Sims","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0130","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.2353\/ajpath.2010.090914","article-title":"Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome\/glaucoma","volume":"176","author":"Zenkel","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.02-0365","article-title":"Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome\/glaucoma and primary open-angle glaucoma","volume":"44","author":"Schlotzer-Schrehardt","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0140","first-page":"50","article-title":"The role of the cytokines in the pathogenesis of pseudoexfoliation syndrome","volume":"6","author":"Yildirim","year":"2013","journal-title":"Int. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0145","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","article-title":"Diabetic macular edema: pathogenesis and treatment","volume":"54","author":"Bhagat","year":"2009","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2008.09.034","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion","volume":"116","author":"Noma","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pathophys.2017.05.005_bib0160","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/459251","article-title":"Inflammatory and angiogenic protein detection in the human vitreous: cytometric bead assay","volume":"2011","author":"Koss","year":"2011","journal-title":"J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.pathophys.2017.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3109\/02713683.2010.510257","article-title":"Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy","volume":"35","author":"Oh","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/02713683.2011.614370","article-title":"Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion","volume":"37","author":"Noma","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0175","article-title":"Aqueous interleukin-6 (IL-6) level is a marker for treatment resistance to bevacizumab in age-related macular dDegeneration\u2014aqueous cytokines after bevacizumab","volume":"2014","author":"Chalam","year":"2014","journal-title":"Open J. Ophthalmol."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/192791","article-title":"Hsv-1 mir-h6 inhibits hsv-1 replication and il-6 expression in human corneal epithelial cells in vitro","volume":"2012","author":"Duan","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0185","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano-and microparticles sustain retinal delivery of budesonide: a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0190","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema","volume":"152","author":"Sohn","year":"2016","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0195","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00417-012-2243-x","article-title":"Tocilizumab treatment for recalcitrant uveitic macular edema","volume":"251","author":"Ad\u00e1n","year":"2013","journal-title":"Graefe\u00e1s Arch. Clin. Exp. Ophthalmol"},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0200","doi-asserted-by":"crossref","first-page":"e19141","DOI":"10.1371\/journal.pone.0019141","article-title":"Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study","volume":"6","author":"Ricker","year":"2011","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.pathophys.2017.05.005_bib0205","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00347-013-2832-z","article-title":"Pharmacological approach to treatment of proliferative vitreoretinopathy","volume":"110","author":"Priglinger","year":"2013","journal-title":"Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft"},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Suzuki","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0215","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejps.2012.08.010","article-title":"Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers","volume":"47","author":"Petersen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jdiacomp.2011.06.002","article-title":"Increased IL-6 levels are not related to NF-\u03baB or HIF-1\u03b1 transcription factors activity in the vitreous of proliferative diabetic retinopathy","volume":"25","author":"Arjamaa","year":"2011","journal-title":"J. Diabetes Complic."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2013.07.014","article-title":"The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments","volume":"50","author":"Varshochian","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0230","first-page":"1325","article-title":"Proliferative vitreoretinopathy: current and emerging treatments","volume":"6","author":"Sadaka","year":"2012","journal-title":"Clin. Ophthalmol. (Auckland, NZ)"},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cyto.2011.02.001","article-title":"Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy","volume":"54","author":"Symeonidis","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0240","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1167\/iovs.09-3375","article-title":"Role of IL-6 in angiotensin II?induced retinal vascular inflammation","volume":"51","author":"Rojas","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1167\/iovs.11-8434","article-title":"Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract","volume":"53","author":"Takai","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"26","key":"10.1016\/j.pathophys.2017.05.005_bib0250","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0255","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mehy.2012.12.042","article-title":"Interleukin-6 in the pathogenesis of posterior capsule opacification and the potential role for interleukin-6 inhibition in the future of cataract surgery","volume":"80","author":"Lewis","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0260","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2672.1998.00418.x","article-title":"Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis","volume":"84","author":"McLaughlin-Borlace","year":"1998","journal-title":"J. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/107999000312441","article-title":"Interleukin-6 levels in tears of contact lens wearers","volume":"20","author":"Schultz","year":"2000","journal-title":"J. Interf. Cytokine Res."},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0270","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ophtha.2012.01.031","article-title":"Association of single nucleotide polymorphisms of interleukins-1\u03b2,-6, and-12B with contact lens keratitis susceptibility and severity","volume":"119","author":"Carnt","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.pathophys.2017.05.005_bib0275","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1167\/iovs.06-0340","article-title":"A protective role for IL-6 in staphylococcal microbial keratitis","volume":"47","author":"Hume","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0280","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/IAI.67.5.2497-2502.1999","article-title":"Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa","volume":"67","author":"Cole","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","article-title":"Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection","volume":"82","author":"Biswas","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.pathophys.2017.05.005_bib0290","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1440-1711.2005.01326.x","article-title":"A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice","volume":"83","author":"Hume","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0295","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/513977","article-title":"Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation","volume":"175","author":"Kriesel","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S0074-02762009000200014","article-title":"Immunopathology in ocular toxoplasmosis: facts and clues","volume":"104","author":"Garweg","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0305","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1111\/aos.12046","article-title":"Interleukin-6 gene polymorphism (\u2212174G\/C) is associated with toxoplasmic retinochoroiditis","volume":"91","author":"Cordeiro","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"8","key":"10.1016\/j.pathophys.2017.05.005_bib0310","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.micron.2008.02.003","article-title":"Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL\/6 mice","volume":"39","author":"Calabrese","year":"2008","journal-title":"Micron"},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.68.1.407-410.2000","article-title":"Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1): IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells","volume":"68","author":"Nagineni","year":"2000","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0320","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/IAI.69.4.2589-2595.2001","article-title":"Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor \u03b2 and a protective role for interleukin-6","volume":"69","author":"Lyons","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0325","first-page":"471","article-title":"Effect of topical 0. 05% cyclosporine A on corneal endothelium in patients with dry eye disease","volume":"004","author":"Rico","year":"2013","journal-title":"Int. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0330","doi-asserted-by":"crossref","first-page":"e45612","DOI":"10.1371\/journal.pone.0045612","article-title":"Selenium compound protects corneal epithelium against oxidative stress","volume":"7","author":"Higuchi","year":"2012","journal-title":"PloS One"},{"issue":"13","key":"10.1016\/j.pathophys.2017.05.005_bib0335","article-title":"Multiple cytokine evaluation in tears of allergic conjunctivitis patients by Multi-Cytokine Bead Assay","volume":"45","author":"Leonardi","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","article-title":"Vernal keratoconjunctivitis: a major review","volume":"87","author":"Kumar","year":"2009","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0345","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2006.02499.x","article-title":"Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures","volume":"36","author":"Leonardi","year":"2006","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0350","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jcp.21926","article-title":"Induction of Th17 differentiation by corneal epithelial-derived cytokines","volume":"222","author":"Zheng","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12017-014-8335-5","article-title":"miR26a modulates Th17\/Treg balance in the EAE model of multiple sclerosis by targeting IL6","volume":"17","author":"Zhang","year":"2015","journal-title":"Neuromol. Med."},{"issue":"72","key":"10.1016\/j.pathophys.2017.05.005_bib0365","first-page":"S73","article-title":"Case report Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report","volume":"30","author":"Urbaniak","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","article-title":"Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses","volume":"91","author":"Hohki","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0375","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/ken489","article-title":"Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis","volume":"48","author":"Yoshimura","year":"2009","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0380","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1189\/jlb.0805453","article-title":"Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-\u03baB (NF-\u03baB), pyrrolidine dithiocarbamate","volume":"79","author":"Kitamei","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0385","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1167\/iovs.10-6272","article-title":"Blockade of interleukin-6 signaling suppresses not only Th17 but also interphotoreceptor retinoid binding protein\u2013specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis","volume":"52","author":"Haruta","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et\u2019s disease with ocular involvement","volume":"12","author":"Bardak","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0395","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/s10165-011-0497-5","article-title":"A case of Beh\u00e7et\u2019s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab","volume":"22","author":"Hirano","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"13","key":"10.1016\/j.pathophys.2017.05.005_bib0400","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1167\/iovs.11-9322","article-title":"Profile of local interleukin expression in a cohort of ocular cicatricial pemphigoid patients","volume":"53","author":"Suelves","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.pathophys.2017.05.005_bib0405","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10428199509051718","article-title":"Cytokine dysregulation in chronic graft versus host disease","volume":"17","author":"Barak","year":"1995","journal-title":"Leuk. lymphoma"},{"key":"10.1016\/j.pathophys.2017.05.005_bib0410","first-page":"797","article-title":"Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"18","author":"Riemens","year":"2012","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archopthalmol.2011.1472","article-title":"Downregulation of monocyte chemoattractant protein 1 expression by prostaglandin e2 in human ocular surface epithelium","volume":"130","author":"Ueta","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0420","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1076\/ceyr.16.7.670.5057","article-title":"Cytokine expression in the alkali-burned cornea","volume":"16","author":"Sotozono","year":"1997","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0425","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/09273949709085057","article-title":"Trauma and alkali burns induce distinct patterns of cytokine gene expression in the rat cornea","volume":"5","author":"Planck","year":"1997","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0430","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1097\/00003226-200011003-00004","article-title":"Second injury in the cornea: the role of inflammatory cytokines in corneal damage and repair","volume":"19","author":"Sotozono","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.pathophys.2017.05.005_bib0435","first-page":"2665","article-title":"Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells-chemically injured keratocyte reaction","volume":"17","author":"Yi","year":"2011","journal-title":"Mol. Vis."},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0440","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1167\/iovs.13-11684","article-title":"Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-b1\/ERK pathways regulation","volume":"54","author":"Shin","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0445","first-page":"2055","article-title":"Proteomic analysis of the tear film in patients with keratoconus","volume":"16","author":"Lema","year":"2010","journal-title":"Mol. Vis."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0450","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ophtha.2004.11.050","article-title":"Inflammatory molecules in the tears of patients with keratoconus","volume":"112","author":"Lema","year":"2005","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0455","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/bjo.2008.144253","article-title":"Subclinical keratoconus and inflammatory molecules from tears","volume":"93","author":"Lema","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"13","key":"10.1016\/j.pathophys.2017.05.005_bib0460","article-title":"Inflammatory markers in keratoconus","volume":"44","author":"Duran","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0465","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/cxo.12038","article-title":"Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus","volume":"96","author":"Balasubramanian","year":"2013","journal-title":"Clin. Exp. Optom."},{"issue":"S1","key":"10.1016\/j.pathophys.2017.05.005_bib0470","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02713689208999531","article-title":"Cytokines in human intraocular inflammation","volume":"11","author":"Franks","year":"1992","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0475","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exer.2012.02.015","article-title":"Anti-inflammatory effect of IL-6 receptor blockade in corneal alkali burn","volume":"97","author":"Sakimoto","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0480","first-page":"153","article-title":"Azithromycin reduces inflammation in a rat model of acute conjunctivitis","volume":"19","author":"Fernandez-Robredo","year":"2013","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0485","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/labinvest.2011.132","article-title":"Vision preservation during retinal inflammation by anthocyanin-rich bilberry extract: cellular and molecular mechanism","volume":"92","author":"Miyake","year":"2012","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0490","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cellimm.2011.11.003","article-title":"Tannic acid suppresses ultraviolet B-induced inflammatory signaling and complement factor B on human retinal pigment epithelial cells","volume":"273","author":"Chou","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.pathophys.2017.05.005_bib0495","first-page":"1799","article-title":"Cis-urocanic acid suppresses UV-B-induced interleukin-6 and-8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro","volume":"15","author":"Viiri","year":"2009","journal-title":"Mol. Vis."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0500","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/02713683.2012.763103","article-title":"Heat effect induces production of inflammatory cytokines through heat shock protein 90 pathway in cornea cells","volume":"38","author":"Tsai","year":"2013","journal-title":"Curr. Eye Res."},{"issue":"12","key":"10.1016\/j.pathophys.2017.05.005_bib0505","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1167\/iovs.12-9861","article-title":"Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-\u03baB","volume":"53","author":"Gillespie","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.pathophys.2017.05.005_bib0510","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-011-1863-x","article-title":"Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy","volume":"250","author":"Huang","year":"2012","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pathophys.2017.05.005_bib0515","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/105072501753210984","article-title":"Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves\u2019 ophthalmopathy","volume":"11","author":"Jyonouchi","year":"2001","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0525","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ophtha.2012.11.007","article-title":"Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma","volume":"120","author":"Missotten","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.pathophys.2017.05.005_bib0530","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00277-012-1479-1","article-title":"Primary intraocular lymphoma in a patient with systemic lupus erythematosus","volume":"91","author":"Woei-A-Jin","year":"2012","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0535","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9394(14)72217-2","article-title":"Interleukin-10 in the vitreous of patients with primary intraocular lymphoma","volume":"120","author":"Chan","year":"1995","journal-title":"Am. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pathophys.2017.05.005_bib0540","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archopht.1997.01100160327010","article-title":"Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma","volume":"115","author":"Whitcup","year":"1997","journal-title":"Arch. Ophthalmol."},{"issue":"968180","key":"10.1016\/j.pathophys.2017.05.005_bib0545","first-page":"6","article-title":"Refractory uveitis in patient with castleman disease successfully treated with tocilizumab","volume":"1155","author":"Oshitari","year":"2012","journal-title":"Case Rep. Ophthalmol. Med."},{"issue":"1","key":"10.1016\/j.pathophys.2017.05.005_bib0550","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-5699(91)90107-5","article-title":"Fibrogenic cytokines: the role of immune mediators in the development of scar tissue","volume":"12","author":"Kovacs","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.pathophys.2017.05.005_bib0555","first-page":"2123","article-title":"TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon\u2019s fibroblasts to myofibroblasts","volume":"15","author":"Seong","year":"2009","journal-title":"Mol. Vis."},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0560","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.exer.2005.09.021","article-title":"Stromal haze: myofibroblasts, and surface irregularity after PRK","volume":"82","author":"Netto","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"12","key":"10.1016\/j.pathophys.2017.05.005_bib0565","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1167\/iovs.11-7956","article-title":"Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing","volume":"52","author":"Ebihara","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.pathophys.2017.05.005_bib0570","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/cyto.1999.0598","article-title":"Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair","volume":"12","author":"Liechty","year":"2000","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.pathophys.2017.05.005_bib0575","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.2042-7158.2011.01292.x","article-title":"Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars","volume":"63","author":"Matsui","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.pathophys.2017.05.005_bib0580","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/09273948.2011.606593","article-title":"Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis","volume":"19","author":"Muselier","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"2","key":"10.1016\/j.pathophys.2017.05.005_bib0585","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000069006","article-title":"Pseudomonas aeruginosa keratitis in IL-6-deficient mice","volume":"130","author":"Cole","year":"2003","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468017300342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468017300342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T20:44:07Z","timestamp":1602276247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468017300342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0928468017300342"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2017.05.005","relation":{},"ISSN":["0928-4680"],"issn-type":[{"value":"0928-4680","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-6 participation in pathology of ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Pathophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathophys.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}